Showing results (121-130 of 133) with videos related to
Sort By:
Pageof 14
Neoplasma|December 25, 2012
Second line treatment in advanced non-small cell lung cancer (NSCLC): comparison of efficacy of erlotinib and chemotherapyO Fiala, M Pesek, J Finek, et al.Journal of the American Academy of Dermatology|March 1, 1986
Solitary nonepidermotropic T cell pseudolymphoma of the skinS C van der Putte, J Toonstra, P C Felten, et al.Investigative Ophthalmology & Visual Science|March 1, 1993
Platelet-derived growth factor: receptor expression in corneas and effects on corneal cellsV P Hoppenreijs, E Pels, G F Vrensen, et al.Neoplasma|October 17, 2012
Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practiceO Fiala, M Pesek, J Finek, et al.Analytical Chemistry|December 9, 1998
Screening for high-affinity ligands to the Src SH2 domain using capillary isoelectric focusing-electrospray ionization ion trap mass spectrometryY V Lyubarskaya, S A Carr, D Dunnington, et al.Cornea|July 1, 1996
Synergistic action of heparin and serum on basic fibroblast growth factor-modulated DNA synthesis and mitochondrial activity of cultured bovine corneal endothelial cellsV P Hoppenreijs, E Pels, P C Felten, et al.World Journal of Gastroenterology|July 31, 2007
Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancerC Salek, L Benesova, M Zavoral, et al.Neoplasma|August 3, 2013
Erlotinib in the treatment of advanced squamous cell NSCLCO Fiala, M Pesek, J Finek, et al.Neoplasma|March 9, 2016
Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinibO Fiala, M Pesek, J Finek, et al.Analytical Biochemistry|July 4, 2012
Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patientsL Benesova, B Belsanova, S Suchanek, et al.Pageof 14